AXIM BIOTECHNOLOGIES, INC. (AXIM) Operating income 2014–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual operating income history from SEC filings — each fiscal year as reported.
-$2.8MFY2023 · since FY2014: -$505,729 → -$2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$2.8M | +40.9% |
| FY2022 | -$4.7M | +66.7% |
| FY2021 | -$14.0M | -182.4% |
| FY2020 | -$4.9M | -59.2% |
| FY2019 | -$3.1M | +38.3% |
| FY2018 | -$5.0M | -59.9% |
| FY2017 | -$3.1M | +16.2% |
| FY2016 | -$3.8M | +62.6% |
| FY2015 | -$10.0M | -1887.1% |
| FY2014 | -$505,729 | — |
Source: SEC XBRL filings · For reference only · Not investment advice